Last update 29 Mar 2025

HRS-1167

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HRS 1167, HRS1167, M9466
Target
Action
inhibitors
Mechanism
PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors)
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Prostate CarcinomaPhase 2
China
06 Sep 2024
Recurrent ovarian cancerPhase 2
China
15 Mar 2024
Locally Advanced Malignant Solid NeoplasmPhase 1
Japan
01 Jul 2025
Metastatic Colorectal CarcinomaPhase 1
United States
08 Oct 2024
Metastatic Colorectal CarcinomaPhase 1
Japan
08 Oct 2024
Metastatic Colorectal CarcinomaPhase 1
Australia
08 Oct 2024
Metastatic Colorectal CarcinomaPhase 1
Spain
08 Oct 2024
Advanced Malignant Solid NeoplasmPhase 1
China
23 Aug 2022
Solid tumorPreclinical
United States
31 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
Advanced Malignant Solid Neoplasm
Homologous Recombination Deficiency Positive
40
HRS-1167 300 mg
zbmnlzcmek(xhaypvrtpx) = None dzxyegmzyi (xkrvckoxdp )
Positive
24 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free